In this study, we combined the enrichment of homogeneous cancer cells through microdissection and the analysis of RNA without amplification to identify differentially regulated genes in prostate tumors of non-BCR and BCR patients that could be used as prognostic biomarkers for progression to BCR. This evidence concerns the gene BCR and prostate neoplasm.